Table 1 Characteristics of 125 patients with chronic hepatitis C
Variables | Median (25th-75thpercentile values) or number (percentage) |
|---|---|
Age (years) | 57 (25-64) |
Gender (male/female) | 65/60 (52/48) |
BMI (kg/m2) | 24.8 (23.0-27.0) |
Albumin (g/dL) | 4.1 (3.9-4.4) |
Total bilirubin (mg/dL) | 0.7 (0.6-1.0) |
AST (U/L) | 107 (72-159) |
ALT (U/L) | 160 (109-259) |
ALK-p (U/L) | 96 (72-121) |
PT INR | 1.04 (1.01-1.08) |
WBC (/mm3) | 5,120 (4,403-6,083) |
Hgb (g/dL) | 14.4 (13.3-15.5) |
Platelets (/μL) | 125,000 (110,000-140,500) |
Fibrosis (F1/2/3/4) | 2/31/39/19 (1.6/24.8/31.2/15.2)# |
Necroinflammatory activity (A0/1/2/3) | 13/49/21/3 (10.4/38.2/16.8/2.4)# |
Cirrhosis status (yes/no) | 28/97 (22.4/77.6) |
HCV-RNA (log10, IU/mL) | 6.12 (5.39-6.66) |
HCV genotype (1/2) | 71/54 (56.8/43.2) |
Splenomegaly (yes/no) | 27/97 (21.6/77.6)§ |
Peg-IFN-α-2a/-α-2b | 48/77 (38.4/61.6) |
Dose of ribavirin (mg/day) | 867 (800-1000) |